Robert Foster, Hepion Pharmaceuticals CEO and Aurinia board member
Aurinia appoints founder to board in handshake with MKT Capital
As Aurinia Pharmaceuticals explores a potential sale and refreshes its board following pushback from MKT Capital and another investor group, the drugmaker has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
